The FDA has Traditionally favored abstinence since the endpoint in trials to acquire drugs for material use Problems. Abstinence continues to be evaluated employing absence of optimistic urine drug assessments, absence of self-noted drug use, and on a regular basis attending sessions wherever drug use is assessed.For people with addictions to drugs